GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Innovative Pharmaceutical Biotech Ltd (HKSE:00399) » Definitions » Cash Flow from Others

Innovative Pharmaceutical Biotech (HKSE:00399) Cash Flow from Others : HK$-13.63 Mil (TTM As of Sep. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Innovative Pharmaceutical Biotech Cash Flow from Others?

Innovative Pharmaceutical Biotech's cash flow from others for the six months ended in Sep. 2024 was HK$-103.60 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2024 was HK$-13.63 Mil.


Innovative Pharmaceutical Biotech Cash Flow from Others Historical Data

The historical data trend for Innovative Pharmaceutical Biotech's Cash Flow from Others can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovative Pharmaceutical Biotech Cash Flow from Others Chart

Innovative Pharmaceutical Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cash Flow from Others
Get a 7-Day Free Trial Premium Member Only Premium Member Only 190.15 190.84 -60.78 233.79 -112.21

Innovative Pharmaceutical Biotech Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Cash Flow from Others Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 115.41 121.62 -196.96 89.97 -103.60

Innovative Pharmaceutical Biotech Cash Flow from Others Calculation

Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-13.63 Mil.

Innovative Pharmaceutical Biotech Cash Flow from Others Related Terms

Thank you for viewing the detailed overview of Innovative Pharmaceutical Biotech's Cash Flow from Others provided by GuruFocus.com. Please click on the following links to see related term pages.


Innovative Pharmaceutical Biotech Business Description

Traded in Other Exchanges
N/A
Address
145 Hennessy Road, Unit No. 2002, 20th Floor, On Hong Commercial Building, Wan Chai, Hong Kong, HKG
Innovative Pharmaceutical Biotech Ltd is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The company has two operating segments; Trading of beauty products in Hong Kong and Research, development, and commercialisation of the oral insulin product. The company generates almost all of its revenue from Hong Kong.
Executives
Chau Yiu Ting 2101 Beneficial owner
Mao Yumin 2101 Beneficial owner
Extrawell Pharmaceutical Holdings Limited
Mao Yumin 2101 Beneficial owner
Chau Yiu Ting 2101 Beneficial owner

Innovative Pharmaceutical Biotech Headlines

No Headlines